It must be diluted to 10-20mg/ml before use it. Beware of dilute with sodium bicarbonate solutions. In Supra ventricular Taquicardia: response i often acquired with doses of 50-200mcgs/kg/min now that higher doses doesn't yield a better response and augment the adverse reactions risk. Initiate treatment with 500mcg/kg/min for a minute and then continue with a mantenance dose of 50 mcg/kg/min for 4 minutes. In case of enought quantity, repeat the squeme: load 500mcg/kg/min and menteinance dose 150mcgs/kg/min for 4 minutes. When desired effect is acquired continue with 200 mcgs/kg/min.
Mostrando entradas con la etiqueta Esmolol. Mostrar todas las entradas
Mostrando entradas con la etiqueta Esmolol. Mostrar todas las entradas
domingo, 17 de abril de 2011
Esmolol
Esmolol is an ultra-short–acting B 1-selective adrenoceptor antagonist. The structure of esmolol contains an ester linkage; esterases in red blood cells rapidly metabolize esmolol to a metabolite that has a low affinity for receptors. Consequently, esmolol has a short half-life (about 10 minutes). Therefore, during continuous infusions of esmolol, steady-state concentrations are achieved quickly, and the therapeutic actions of the drug are terminated rapidly when its infusion is discontinued. Esmolol may be safer to use than longer-acting antagonists in critically ill patients who require a -adrenoceptor antagonist. Esmolol is useful in controlling supraventricular arrhythmias, arrhythmias associated with thyrotoxicosis, perioperative hypertension, and myocardial ischemia in acutely ill patients
Suscribirse a:
Entradas (Atom)